Sign in

Private company

CQENS Technologies Inc.

CQENS Technologies Inc. is an American pharmaceutical preparations company based in Minneapolis.2

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersMinneapolis, United States2
  • Incorporated inDE3
  • Business address170 South Green Valley Parkway, Suite 343, Henderson, Nv 890123
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI5493004TOPRYPXY4HV032
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O Harvard Business Services, Inc., 19958 Lewes, United States2
  • Registered withDivision of Corporations, Department of State, 47680782

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income456789-$13.3M in 2025+10861% since 2019
-$15.0M-$10.0M-$5.0M02019: -$121.4K-$121.4K20192020: -$2.5M-$2.5M2020+1985%2021: -$8.5M-$8.5M2021+234%2022: -$6.2M-$6.2M2022−26%2023: -$4.3M-$4.3M2023−31%2024: -$10.9M-$10.9M2024+155%2025: -$13.3M-$13.3M2025+22%
Net income456789-$13.0M in 2025+9929% since 2019
-$15.0M-$10.0M-$5.0M02019: -$129.9K-$129.9K20192020: -$2.5M-$2.5M2020+1857%2021: -$8.5M-$8.5M2021+233%2022: -$6.2M-$6.2M2022−26%2023: -$4.3M-$4.3M2023−31%2024: -$10.9M-$10.9M2024+153%2025: -$13.0M-$13.0M2025+19%
Fiscal year20192020202120222023202420252026
Cost of revenue$25.0K9
Research and development$630.8K5$668.8K6$1.1M7$1.1M8$1.5M9$2.0M9
Operating expenses$8.5M6$6.2M7$4.3M8$10.9M9$13.3M9
Operating income-$121.4K4-$2.5M5-$8.5M6-$6.2M7-$4.3M8-$10.9M9-$13.3M9
Net income-$129.9K4-$2.5M5-$8.5M6-$6.2M7-$4.3M8-$10.9M9-$13.0M9
Earnings per share-$0.336$0.247-$0.168-$0.419-$0.489
Earnings per share (diluted)$0.247-$0.168-$0.419-$0.489
Shares (weighted, basic)25.7M shares626.0M shares726.1M shares826.4M shares927.3M shares9
Shares (weighted, diluted)26.0M shares726.1M shares826.4M shares927.3M shares9

Compare CQENS Technologies Inc. with another company

Corporate structure

CQENS Technologies Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of CQENS Technologies Inc.

  • Alexander C. Chong Filed SC 13D/A on CQENS Technologies Inc., latest Dec 29, 2023 (4 filings since Dec 14, 2021)
  • CQENS Technologies Inc. Minneapolis, Minnesota, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What CQENS Technologies Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Furniture and fixtures$37.2K9 Dec 31, 2025
Construction in progress$2.3M9 Dec 31, 2025$1.3M9 Dec 31, 2024+76.4%
Operating-lease assets (leased space)$193.2K9 Dec 31, 2025$22.0K9 Dec 31, 2024+779.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$8.9M9 Dec 31, 2025$4.6M9 Dec 31, 2024+93.9%
Deposits held (banks)$850.0K9 Dec 31, 2024

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$1.7M9 Dec 31, 2025$1.4M9 Dec 31, 2024+25.6%

Properties, in its own words

We previously maintained our corporate offices at 5550 Nicollet Avenue, Minneapolis, MN 55419. We leased these premises from 5550 Nicollet LLC, an affiliate of Mr. Chong. From December 2019 through the end of 2024, we entered into month-to-month leases each December at an annual rental rate of $9,300. We continued to rent this same space on a month-to-month basis in 2025 until our relocation to Nevada on December 23, 2025. The monthly rent was $800. Effective December 23, 2025, the Company relocated its corporate offices from 5550 Nicollet Avenue, Minneapolis, MN 55419 to 170 S Green Valley Parkway, Suite 343, Henderson, NV 89012. The lease of the corporate office facilities in Henderson, NV, is for a term of 12 months at an approximate cost of $1,441 per month. The facilities are sufficient to maintain the Company’s current executive operations.

Effective April 15, 2022, the Company entered into a lease agreement for research and development and product engineering space located at 8035 Soquel Drive, #41, Aptos, California. The initial term of the lease was three years ending April 30, 2025. The Company extended the lease for an additional 2-year term commencing May 1, 2025 through April 30, 2027. The Company pays an escalating base rent over the life of the lease of initially $4,800 per month increased to $5,175 in May 2023, then $5,555 in June of 2024. The rate increased in June 2025 to $5,930 per month. The Company’s pro rata portion of property expenses and operating expenses is included in this rent.

The rest of Item 2

On November 10, 2025, we entered into a 2-year lease agreement for research and development space located at Room 407, Building 6, Qianhai Kexing Science Park, Laodong Community, Xixiang Subdistrict, Bao’an District, Shenzhen, Guangdong Province P.R. China. The rent is fixed for the duration of the term. Common area maintenance is included in the rent. The rent is 34,373 RMB per month or approximately $4,878 USD per month.

Item 2 of the 10-K filed Apr 15, 2026.12

Leadership

Who has led CQENS Technologies Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Alexander C. Chong2015–2023

President

  1. William Bartkowski2015–2022

Chief financial officer

  1. Daniel Markes2015–now

Chief operating officer

  1. William Bartkowski2015–2022
  2. Markus Karl Paul Joachim Bonke2026–now
20202025
Board members and other officers (7)

Former names

  • VapAria CorpAug 21, 2014 to Dec 18, 20193
  • OICco ACQUISITION IV, INC.Mar 29, 2010 to Aug 12, 20143

Timeline

  1. Sep 3, 20268-K Other events21
  2. Mar 5, 20268-K Executive or director change; Regulation FD disclosure22
  3. Dec 30, 20258-K Other events23
  4. Jul 17, 20258-K Regulation FD disclosure24
  5. Jun 10, 20258-K Entered a material agreement25
  6. Nov 20, 20248-K Regulation FD disclosure26
  7. Aug 6, 20248-K Regulation FD disclosure27
  8. Jun 25, 20248-K Executive or director change28
  9. Apr 19, 20248-K Regulation FD disclosure29
  10. Dec 29, 20238-K Regulation FD disclosure30
  11. Dec 21, 20238-K Entered a material agreement31
  12. Nov 22, 20238-K Entered a material agreement32
  13. Jul 22, 2015New chief executive Alexander C. Chong becomes CEO13
  14. Dec 21, 2009Founded CQENS Technologies Inc. is founded2

Filings

70 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 23 major events, 14 insider forms, 4 large holders, 1 private raises, 8 other. The latest 20:

  1. Sep 3, 20268-K EDGAR
  2. Aug 19, 202610-Q EDGAR
  3. Aug 13, 2026NT 10-Q EDGAR
  4. May 14, 202610-Q EDGAR
  5. Apr 22, 20263 EDGAR
  6. Apr 16, 20263 EDGAR
  7. Apr 15, 202610-K EDGAR
  8. Apr 15, 20265 EDGAR
  9. Apr 15, 20265 EDGAR
  10. Apr 13, 20263 EDGAR
  11. Mar 31, 2026NT 10-K EDGAR
  12. Mar 5, 20268-K EDGAR
  13. Dec 30, 20258-K EDGAR
  14. Nov 13, 202510-Q EDGAR
  15. Aug 14, 202510-Q EDGAR
  16. Jul 17, 20258-K EDGAR
  17. Jul 10, 2025DEF 14C EDGAR
  18. Jun 10, 20258-K EDGAR
  19. May 13, 202510-Q QUARTERLY REPORT EDGAR
  20. Mar 31, 202510-K EDGAR

The 70 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. May 7, 2024Raised $6.9 million in a private offering of equity Form D: $20 million offered in all Form D

SEC filer profile

How CQENS Technologies Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCQENS Technologies Inc.1
  • CIK0001479915
  • Employer ID (EIN)27-152140712
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company12
  • Incorporated inDelaware12
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address170 South Green Valley Parkway, Suite 343, Henderson, NV 890121
  • Phone612-812-20371
  • Shares outstanding27,591,252 as of Aug 17, 202611
  • Public float$0 as of Jun 30, 20259
  • AuditorMaloneBailey, LLP, Houston, TX PCAOB ID 206; no auditor attestation of internal control over financial reporting12
  • On EDGAR sinceMar 29, 20101
  • Filings218 in all: 8-K (44), 10-Q (38), 4 (36), CORRESP (15), UPLOAD (15), 10-K (13), S-1/A (10), NT 10-K (9)1
    All 26 form types

    3 (7), NT 10-Q (4), POS AM (4), DEF 14C (3), SC 13D/A (3), 10-Q/A (2), 5 (2), EFFECT (2), PRE 14C (2), 10-K/A (1), 424B3 (1), 8-A12G (1), 8-K/A (1), D (1), NTN 10Q (1), PRER14C (1), S-1 (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Apr 15, 2026
    Quarterly report (10-Q) Aug 19, 2026
    Latest 8-K (8-K) Sep 3, 2026

Risk factors and legal proceedings

The risks CQENS Technologies Inc. names in Item 1A of its 10-K filed Apr 15, 2026: 14 risks under these headings, as written.12

  • FINANCIAL RISKS
  • We have a history of losses and we do not generate any revenues.
  • Our auditors have raised substantial doubts in our ability to continue as a going concern.
  • We will require additional capital to fund our operations and although we have been successful raising capital to date, we cannot guarantee this will continue. Should we be unsuccessful in raising capital, we could be forced to cease operations.
  • BUSINESS RISKS
  • We have a limited operating history and have not launched any products.
  • There are no assurances the Barker Group/Firebird Manufacturing joint venture will be finalized.
  • In addition to management’s full-time or near full-time commitment to the Company, certain of our officers and directors have other interests and obligations outside of CQENS and may have conflicts of interest.
  • We rely on a third-party manufacturer of our production line equipment for our consumables and our joint venture partners for production of our devices and consumables.
  • Certain of our proposed products will be subject to FDA oversight.
  • We have not marketed, sold or distributed products and have limited capacity and resources at this time.
  • We may not be successful in establishing and maintaining a strategic partnership, which could adversely affect our ability to commercialize our proposed products.
The other 4 risks
  • To the extent we elect to enter into licensing or collaboration agreements to partner our candidate products, our dependence on such relationships may adversely affect our business.
  • Tariffs may adversely affect our business.
  • RISK RELATED TO OUR COMMON STOCK
  • There is no public market for our common stock. In the event we establish a market for our common stock, it is likely that the market for that common stock will be limited.
  • Delaware law contains anti-takeover provisions that could deter takeover attempts that could be beneficial to our stockholders.

Legal proceedings

We are not a party to any pending or threatened litigation.

The opening of Item 3, Legal Proceedings.12

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
    SEC EDGAROther events
  22. 22
  23. 23
    SEC EDGAROther events
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33